#financial results

Collection of financial results news, found 112 news.

Celltrion’s monoclonal antibody treatment regdanvimab, approved by the European Commission for the treatment of COVID-19

Celltrion Group announced today that the European Commission (EC) has approved Regkirona (regdanvimab, CT-P59), one of ...

Yili Group reports operating revenue of RMB 85 billion in the first three quarters of 2021, with a net profit growth of over 30%

On October 28, 2021, Yili Group released its financial results for the first three quarters of 2021. During the ...

Celltrion receives CHMP positive opinion for regdanvimab (CT-P59) as one of the first monoclonal antibodies recommended as a treatment for COVID-19 by the CHMP

Celltrion Group announced today that the European Medicine’s Agency’s (EMA) Committee for Medicinal Products for ...

Zynga announces third quarter 2021 financial results

Zynga Inc. (Nasdaq: ZNGA) today released financial results for its third quarter ending September 30, 2021 by posting ...

Zynga closes acquisition of mobile game developer StarLark; expands game portfolio with hit franchise, Golf Rival

Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced it has closed the acquisition ...

Australia successfully goes live With Everbridge Public Warning platform countrywide, representing official launch of the Australian Government’s next-generation national population alerting system

Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM) and national Public Warning ...

Procore to acquire Levelset to simplify lien management workflows for construction

Procore Technologies, Inc., (NYSE: PCOR), a leading provider of construction management software, has signed a ...

Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)

Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a ...

ITT issues 2021 sustainability report supplement; continues progress on environmental, social and governance priorities

September 9, 2021-- ITT Inc. (NYSE: ITT) has released Sustainability ITT – 2021 Supplement, its second supplement to ...

Zynga announces second quarter 2021 financial results

Zynga Inc. (Nasdaq: ZNGA) today released financial results for its first quarter ending June 30, 2021 by posting ...

Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment

infected animals was confirmed with a clinical dosage of regdanvimab (CT-P59)1 Incheon, South Korea--(Antara/Business ...

Zynga announces first quarter 2021 financial results

Zynga Inc. (Nasdaq: ZNGA) today released financial results for its first quarter ended March 31, 2021 by posting ...

Egon Zehnder reports strong 2020 results amid pandemic and economic crisis

Egon Zehnder, the world’s leadership advisory firm, today announced strong 2020 annual results, despite a ...

ReNew Power, India’s leading renewable energy company, to publicly list through business combination with RMG Acquisition Corporation II in $8 billion transaction

ReNew Power Private Limited (“ReNew” or “the Company”), India’s leading pure-play renewable energy producer, ...

Zynga announces fourth quarter and full year 2020 financial results

Zynga Inc. (Nasdaq: ZNGA) today released financial results for its fourth quarter and full year ended December 31, ...